This session addresses the growing field of medical isotope production and the implications for criticality safety. The field involves a number of emerging techniques and technologies which produce criticality safety challenges, INCLUDING handling high-assay low-enriched uranium in known or new chemical compositions. These challenges create opportunities for advancements in criticality safety techniques and demonstrate a continuing need for nuclear data. This panel is designed to highlight challenges, advancements, and current or future needs in the field of criticality safety for medical isotope production facilities.

Speakers

Jeff Chapman

National Nuclear Security Administration

Joseph Christensen

SHINE Medical Technologies

Katherin Goluoglu

Isotek Systems, LLC

William Magwood, IV

OECD/Nuclear Energy Agency

Session Recording

To access the session recording, you must be logged in and registered for the meeting.

Register NowLog In

Discussion

There are 5 comments in this discussion.

To join the conversation, you must be logged in and registered for the meeting.

Register NowLog In